News
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Results come after positive results from a trial among people with idiopathic pulmomary disease.
An investigational oral targeted therapy, zipalertinib (CLN-081), demonstrated meaningful tumor responses and a manageable ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
The healthcare provisions include Medicaid work requirements and a broadening of the exemption to Medicare drug price negotiation ...
After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...
In a conversation with Managed Healthcare Executive, Michael Abrams, M.A., managing partner at Numerof & Associates, painted ...
Climate change and air pollution are growing threats to public health, and new research suggests they may also worsen atopic ...
Competition is Key to Healthcare System Stability for Employers, Providers and Patients, Expert Says
While the impact of Medicaid changes on employer-sponsored insurance remains to be seen, competition between providers is a ...
In an opinion article, investigators argue that gene therapies may not achieve their full potential if the innate inflammation in Duchenne muscular dystrophy is not effectively managed.
According to the latest edition of The Cancer Atlas, lower-income nations are experiencing a rise in lung, colorectal and ...
Care gaps in women’s health are closing, thanks to increased cultural awareness of gendered healthcare disparities, according ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback